Featured Product
Advertisement
SYNTHIA™ Retrosynthesis Software
Expert-coded by chemists and engineered by computer scientists, SYNTHIA™ Retrosynthesis Software allows scientists to quickly discover novel pathways for new and published target molecules. Developed over a 15 year period , this SaaS based software platform develops synthetic routes using expert-coded rules based on proven chemical transformations. With a catalog of over 9 million commercially available starting materials and building blocks, SYNTHIA™ provides direct access to real-time local pricing and availability through the Sigma-Aldrich® web shop
Product Specifications
Free Options:
Free Trial
Support Options:
Business Hours, Online
Training Options:
Documentation | Live Online | Webinars | In Person | Videos
Support Cost:
Included with Purchase
Training Cost:
Included with Purchase
Does your product offer an API?
Yes
Featured Content
About Merck KGaA, Darmstadt, Germany
Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From providing products and services that accelerate drug development and manufacturing as well as discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2022, Merck generated sales of € 22.2 billion in 66 countries.
Scientific exploration and responsible entrepreneurship have been key to Merck’s technological and scientific advances. This is how Merck has thrived since its founding in 1668. The founding family remains the majority owner of the publicly listed company. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the business sectors of Merck operate as MilliporeSigma in life science, EMD Serono in healthcare, and EMD Electronics in electronics.
